These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 22091601)
41. Microscope field size and the neuropathologic criteria for Alzheimer's disease. Petrovitch H; Nelson J; Snowdon D; Davis DG; Ross GW; Li CY; White L Neurology; 1997 Oct; 49(4):1175-6. PubMed ID: 9339717 [No Abstract] [Full Text] [Related]
42. [Whole body PET imaging standardizations for the multi-center trials of the JSRT Research Group]. Matsumoto K Nihon Hoshasen Gijutsu Gakkai Zasshi; 2009 May; 65(5):668-80. PubMed ID: 19498257 [No Abstract] [Full Text] [Related]
44. Monitoring the amyloid beta-peptide in vivo--caveat emptor. Thompson PW; Lockhart A Drug Discov Today; 2009 Mar; 14(5-6):241-51. PubMed ID: 19135168 [TBL] [Abstract][Full Text] [Related]
45. Alzheimer's biomarker initiative hits its stride. Miller G Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956 [No Abstract] [Full Text] [Related]
46. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease. Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510 [TBL] [Abstract][Full Text] [Related]
47. Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies. Seibyl J; Zubal IG; Jennings D; Marek K; Doraiswamy PM Expert Rev Neurother; 2011 Dec; 11(12):1783-93. PubMed ID: 22091601 [TBL] [Abstract][Full Text] [Related]